Skip to main content

Table 1 Study characteristics

From: Postoperative complications and prognosis after radical gastrectomy for gastric cancer: a systematic review and meta-analysis of observational studies

Author, year

NOS score

Country

Samplea size

Period

Complications type

Comparable

In-hospital death

5-year RFSb

5-year OSb

Pathological stage

Chemotherapy

Tsujimoto et al. 2009 [13]

8

Japan

141/1191

1986–2005

Infectious

Not

Not*

Excluded

NR

57.9% vs. 78.1%

Sierzega et al. 2010 [14]

7

Poland

41/649

1999–2004

Leakage

NR

NR

Involved

NR

NR

Yoo et al. 2011 [15]

6

Korea

32/446

2000–2005

Leakage

Yes

NR

Involved

NR

9.4% vs. 68.4%

Nagasako et al. 2012 [16]

6

Japan

37/363

1997–2008

Anastomotic

NR

NR

Involved

NR

81% vs. 94.2%

Li et al. 2013 [17]

7

China

51/378

2005–2006

Overall

NR

NR

Involved

NR

21.8%vs. 39.9%

Tokunaga et al. 2013 [18]

6

Japan

81/684

2002–2006

Intra-abdominal infectious

Not

None

Involved

64.9% vs. 84.5%

66.4% vs. 86.8%

Kubota et al. 2014 [19]

7

Japan

207/981

2005–2008

Overall CD ≥ 2

Not

NR

Excluded

NR

84.1% vs. 93.1%

Hayashi et al. 2015 [20]

7

Japan

52/450

2000–2005

Infectious CD ≥ 2

Not

None

None

NR

58% vs. 83%

Kim et al. 2015 [8]

7

Korea

72/3755

2003–2012

Leakage

NR

NR

None

NR

70.8% vs. 79.3%

Saito al. 2015 [9]

6

Japan

86/219

2001–2012

Overall CD ≥ 2

NR

NR

NR

53.4% vs. 70.5%

NR

Jin et al. 2016 [21]

6

U.S.A

336/488

2000–2012

Overall

Not

Not

Excluded

23% vs. 40%

27% vs. 43%

Abdul Kader et al. 2016 [22]

7

Japan

38/227

1991–2010

Intra-abdominal

Yes

Yes

Involved

NR

24.6% vs. 69.2%

Climent et al. 2016 [10]

8

Spain

162/109

1990–2009

Overall CD ≥ 2/infectious

Yes

Yes

Excluded

46.9% vs. 54.1%

48.1% vs. 56.9%

Li et al. 2018 [23]

8

China

86/172

2008–2015

Overall CD > 2

Yes

NA

Excluded

NA

46.3% vs. 65.9%

Eto et al. 2018 [11]

9

Japan

35/66

2005–2015

Overall CD ≥ 2

Yes

Yes

None

41.7% vs. 43.9%

58.2% vs. 56.3%

Watanabe et al. 2018 [12]

7

Japan

134/296

1992–2010

Overall CD > 2

Not

Yes

Involved

46.9% vs. 45.0%

51.3% vs. 47.6%

  1. CD Clavien–Dindo classification of surgical complications, NOS Newcastle-Ottawa Scale, NA not available, NR not reported, OS overall survival, RFS recurrence-free survival
  2. aPatients number with and without concerned complications
  3. bComplications group vs. control group
  4. *More patients in the complication group received adjuvant chemotherapy